Low Free T4 and T3: What Does It Mean If fT4 or fT3 Is Low?

Short Answer

Low free T4 (fT4) shows that there is too little thyroid hormone in the blood. Its meaning becomes clear when it is read together with TSH. According to the TEMD 2025 Thyroid guideline, if TSH is high and fT4 is low, primary hypothyroidism is considered. If fT4 is low while TSH is low or normal, hypothyroidism originating from the pituitary (central) comes to mind. Low fT3 alone, on the other hand, usually does not indicate thyroid disease; it can be seen with severe illness, fasting or the effect of medications. Always evaluate your result according to the laboratory reference range on your report.

How does it appear on your report?

The same test may be written under different names on reports:

• Free T4: "Serbest T4", "sT4", "fT4" or "FT4".
• Free T3: "Serbest T3", "sT3", "fT3" or "FT3".
• TSH: The pituitary hormone that stimulates the thyroid; it is read together with fT4.

The "Tahlillerim" (My Test Results) screen of e-Nabız (Türkiye's national health record app) lists your results together with reference values. Values outside the range are marked in color. With the chart icon, you can see how the same test has changed over time.

Units: In the Test Measurement Units standard of the Turkish Ministry of Health, ng/dL is used for free T4 and ng/L for free T3. Some laboratories, however, report in pmol/L. Numbers in different units cannot be compared directly. For this reason, read each result with the unit and range on its own report.

Why is the "free" form measured? According to TEMD 2025, 99.97% of the T4 in the blood is bound to carrier proteins. What acts on the tissues is the small, unbound free fraction. That is why laboratories mostly measure free T4.

Reference range and decision limit: According to the Ministry of Health procedure, decision limits are marked with an asterisk (*) on the report. The laboratory specialist may also add decision limits to tests such as TSH. For free T4 and T3, you usually see a reference range on the report.

Normal values and reference range

Free T4 and T3 ranges vary by analyzer and method. The values below are example data from Türkiye.

Test	Group	Example range	Source
Free T4	Adult women	12.87–21.36 pmol/L	Ankara multicenter study, 2026
Free T4	Adult men	12.82–21.49 pmol/L	Ankara multicenter study, 2026
Free T4	Manufacturer's range for the same analyzer	11.45–22.14 pmol/L	Ankara multicenter study, 2026
Free T3	Adult women	3.46–5.76 pmol/L	Ankara multicenter study, 2026
Free T3	Adult men	3.46–6.04 pmol/L	Ankara multicenter study, 2026
Free T4 and T3	Pregnancy	Trimester- and method-specific range	TEMD 2025; ATA 2026

These ranges were calculated from more than 100,000 routine results with a single analyzer brand. Your laboratory's range may be different; the range on your report is the one that applies. A reference range covers 95% of healthy people; about 1 in 20 healthy people may fall slightly outside the range.

When comparing two results, do not get hung up on small differences. In a 2025 study with healthy volunteers in Türkiye, a decrease of about 12.7% or an increase of 14.5% was needed for a change in fT4 to be considered real. In the same study, this threshold for fT3 was a decrease of 10.4% or an increase of 11.6%.

What does it mean if it is low?

The causes are listed from common and harmless to rare and serious.

1. Measurement-related situations. According to TEMD 2025, intensive care illness, malnutrition and some medications can make the fT4 measurement misleading. In later stages of pregnancy, commonly used methods can also show fT4 as lower than it really is.

2. Non-thyroidal illness syndrome. This picture is also called "euthyroid sick syndrome" or "low T3 syndrome." According to TEMD 2025, thyroid tests change in this way in up to 70% of hospitalized patients. In mild illness, only T3 falls. As the illness becomes more severe, T4 and TSH may also fall. Pneumonia, sepsis, surgery, heart attack, prolonged fasting and kidney failure are known causes. The thyroid gland itself is actually healthy; when the illness passes, the values usually return to normal.

3. Medications. According to TEMD 2025, corticosteroids and dopamine can suppress TSH. Phenytoin, carbamazepine, rifampicin and phenobarbital speed up the elimination of T4 from the body. Amiodarone and lithium can also affect thyroid hormones. Do not stop your medication on your own; talk to your physician.

4. Primary hypothyroidism. The thyroid gland cannot produce enough hormone; TSH rises and fT4 falls. According to TEMD 2025, in regions without iodine deficiency the most common cause is Hashimoto's thyroiditis. In this disease, fT3 often remains normal for a long time. A fall in fT3 as well suggests that the hypothyroidism has progressed.

5. Central hypothyroidism. The problem is not in the thyroid but in the pituitary or hypothalamus that controls it. The European Thyroid Association (ETA) 2018 guideline describes this as a rare type of hypothyroidism. According to TEMD 2025, TSH may be low or normal, and rarely mildly high (5–10 mIU/L). Pituitary tumors, Sheehan syndrome due to bleeding after childbirth, and pituitary surgery or radiation therapy are among the causes. Some cancer drugs (immune checkpoint inhibitors) can also cause it.

When read together

• High TSH + low fT4: Primary (overt) hypothyroidism (TEMD 2025).
• High TSH + normal fT4: Subclinical hypothyroidism; the test is repeated before a treatment decision.
• Low or normal TSH + low fT4: Central hypothyroidism or a temporary change due to severe illness. Cortisol, prolactin and gonadotropins help with the distinction.
• Normal TSH + normal fT4 + low fT3 only: Mostly the effect of non-thyroidal illness or fasting; it is rechecked after recovery.
• High TSH + positive anti-TPO: Favors primary hypothyroidism; suggests Hashimoto's.
• Low TSH + high fT4: Hyperthyroidism; the most common cause is Graves' disease (TEMD 2025, US data). The frequency of toxic nodular goiter increases with iodine deficiency and older age.

Preparing for the test

• Biotin: High-dose biotin in hair and nail supplements can interfere with the test. TEMD 2025 recommends that in people taking biotin, the test be done after a break of at least 2 days. Ask your physician when to take the break.
• Time of day: According to the 2024 Ministry of Health guideline, routine blood is preferably drawn in the morning between 07:00 and 09:00. Reference ranges are also generally set based on morning samples.
• Severe illness: TEMD 2025 does not consider it necessary to order a thyroid test in intensive care if there is no suspicion of thyroid disease. The test should be repeated after the illness has passed.
• Pregnancy: If you are pregnant, tell the laboratory and your physician; interpretation is done by trimester.
• Same laboratory: If possible, have follow-up tests done at the same laboratory; there may be differences between analyzers.

Which doctor, which test?

• First step: A family physician or internal medicine specialist. TSH and fT4 are repeated together.
• Endocrinology: If fT4 is low while TSH is low or normal, during pregnancy, or if pituitary disease is known.
• Additional tests: Anti-TPO; if central disease is suspected, morning cortisol, prolactin, LH and FSH. If needed, the endocrinologist decides on pituitary imaging.
• If it was low while you were in the hospital: A follow-up test after discharge and recovery.
• In pregnancy: An obstetrician-gynecologist and endocrinology evaluate it together.
• Warning: Do not start thyroid medication on your own. According to TEMD 2025, if adrenal insufficiency is also present in central hypothyroidism, it is treated first.

In Türkiye

• National guideline: The current edition of the Thyroid Diseases Diagnosis and Treatment Guideline of the Society of Endocrinology and Metabolism of Turkey (TEMD) is dated 2025. It contains a separate section on non-thyroidal illness syndrome.
• Iodized salt: According to TEMD, the legal regulation for mandatory iodization of table salt was completed in July 1999. The guideline states that mild-to-moderate iodine deficiency persists in our country. Pregnant and breastfeeding women are a special risk group; iodine supplementation should be discussed with your physician.
• Local reference ranges: A 2026 study using data from three hospitals in Ankara drew attention to the limitations of manufacturer ranges. It supported laboratories setting local ranges.
• Personal variation: A 2025 biological variation study conducted in Türkiye showed that individual variation is important in thyroid tests. The authors recommended using a personal change threshold instead of the population range when comparing two results.
• Unit standard: According to the Ministry of Health's 2021 unit list, free T4 is reported in ng/dL and free T3 in ng/L.

When should you seek emergency care?

• If there is confusion, excessive drowsiness, a drop in body temperature or a slow pulse together with known hypothyroidism or very low fT4, call 112 (the emergency number in Türkiye). TEMD 2025 lists these as prominent findings of myxedema coma.
• If a sudden and very severe headache is accompanied by vision loss or double vision, call 112.
• If someone with known pituitary disease has fainting, vomiting that will not stop or marked weakness, go to the emergency department immediately or call 112.
• If the laboratory has called you about a critical value, see a physician or go to the emergency department the same day.

Related tests

• Lab Test Guide: all tests
• Thyroid tests: how are TSH, T3, T4 and anti-TPO interpreted?
• High morning cortisol: stress or Cushing's?
• High parathyroid hormone (PTH) and bone health
• CRP, sedimentation rate and procalcitonin: inflammation tests

What changed? (October 2026)

• Based on the 2025 edition of the TEMD Thyroid Diseases Diagnosis and Treatment Guideline and its recommendations on non-thyroidal illness syndrome.
• Trimester-specific interpretation during pregnancy was emphasized according to the ATA guideline on thyroid disease in pregnancy and the postpartum period published in May 2026.
• Multicenter reference range data from Türkiye dated 2026 and biological variation data dated 2025 were added.

Sources

• Türkiye Endokrinoloji ve Metabolizma Derneği (TEMD). Tiroid Hastalıkları Tanı ve Tedavi Kılavuzu. 2025. https://file.temd.org.tr/Uploads/publications/guides/documents/tiroid2025_11042025.pdf (accessed October 2, 2026)
• T.C. Sağlık Bakanlığı SHGM. Test Ölçüm Birimleri, Versiyon 2. 15.09.2021. https://dosyamerkez.saglik.gov.tr/Eklenti/41467/0/test-olcum-birimleri-versiyon-2-pdfpdf.pdf (accessed October 2, 2026)
• T.C. Sağlık Bakanlığı SHGM. Tıbbi Biyokimya Toplam Test Süreci Rehberi, Yayın No 1287. May 2024. https://dosyamerkez.saglik.gov.tr/Eklenti/48692/0/tibbi-biyokimya-toplam-test-sureci-rehberipdf.pdf (accessed October 2, 2026)
• T.C. Sağlık Bakanlığı SHGM. Karar Sınırı, Kritik Değer ve Ölçüm Birimlerinin Harmonizasyonu Prosedürü. 22.09.2020. https://dosyamerkez.saglik.gov.tr/Eklenti/15143/0/karar-siniri-esik-deger-kriek42009846pdf.pdf (accessed October 2, 2026)
• T.C. Sağlık Bakanlığı. e-Nabız Kullanım Kılavuzu V2.1. 2025. https://enabiz.gov.tr/document/User_Manual.pdf (accessed October 2, 2026)
• Kiren G, Yılmaz Çalık G, Güngören M, Çubukçu HC. Age- and Sex-Specific Reference Intervals for TSH, FT4, and FT3 Derived from the Turkish Multi-Center Cohort. Diagnostics. 2026;16(12):1800. https://doi.org/10.3390/diagnostics16121800 (accessed October 2, 2026)
• Yıldız R, Özkanay H, Arslan FD, Köseoğlu M. Biological variation of TSH, free T3 and free T4 in healthy subjects in Turkey. Biochem Med. 2025;35(1):010706. https://doi.org/10.11613/bm.2025.010706 (accessed October 2, 2026)
• Jonklaas J and the ATA Task Force. Guidelines for the Treatment of Hypothyroidism. Thyroid. 2014;24:1670-1751. https://doi.org/10.1089/thy.2014.0028 (accessed October 2, 2026)
• Persani L and ETA. 2018 ETA Guidelines on the Diagnosis and Management of Central Hypothyroidism. Eur Thyroid J. 2018;7:225-237. https://doi.org/10.1159/000491388 (accessed October 2, 2026)
• Korevaar TIM and the ATA Task Force. American Thyroid Association 2026 Guidelines for Thyroid Disease in Preconception, Pregnancy, and Postpartum. Thyroid. 2026;36(5):481-544. https://doi.org/10.1177/10507256261445624 (accessed October 2, 2026)